Financials

  • Market Capitalization 1.102 M
  • Employee 13
  • Founded 2008
  • CEO N/A
  • Website silexion.com
  • Headquarter Cayman Islands
  • FIGI N/A
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
0
Price to sales ratio
0.34

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
7508
REVBW
Revelation Biosciences, Inc. - Warrant
0.0062 USD-37.37%-37.37%-10.14%-48.33%3.87 M USD
7509
SXTPW
60 Degrees Pharmaceuticals, Inc. - Warrant
0.0298 USD0.00%+6.43%-20.74%-14.86%3.94 M USD
7520
CDTTW
CDT Equity Inc. - Warrant
0.0110 USD0.00%-30.38%-17.91%-12.00%1.75 M USD
7613
GLTO
Galecto Inc
28.69 USD0.00%-0.21%-6.00%+764.16%1.64 B USD

Frequently asked questions about Silexion Therapeutics Corp - Warrant

What is the Silexion Therapeutics Corp - Warrant stock price today?

The current price of Silexion Therapeutics Corp - Warrant (SLXNW) is 0.025. Over the past 24 hours, the stock has changed by -16.11%. Follow the SLXNW chart for real-time price dynamics.

What is the stock ticker of Silexion Therapeutics Corp - Warrant?

Silexion Therapeutics Corp - Warrant trades under the ticker SLXNW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Silexion Therapeutics Corp - Warrant stock going up?

SLXNW has changed by -16.11% over the last week, -28.57% over the last month, and -37.66% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Silexion Therapeutics Corp - Warrant net income for the last quarter?

Silexion Therapeutics Corp - Warrant reported net income of -2.73 M for the last quarter. The previous quarter showed -4.41 M, which means net income changed by +38.06%.

How many employees does Silexion Therapeutics Corp - Warrant have?

As of the latest available data, Silexion Therapeutics Corp - Warrant has 13 employees. Workforce size can provide additional context about the company's scale and operations.

What is Silexion Therapeutics Corp - Warrant EBITDA?

Silexion Therapeutics Corp - Warrant EBITDA is -2.74 M, and its EBITDA margin is -10.13 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Silexion Therapeutics Corp - Warrant stock?

You can buy Silexion Therapeutics Corp - Warrant (SLXNW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Silexion Therapeutics Corp - Warrant stock?

Investing in Silexion Therapeutics Corp - Warrant requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SLXNW chart and related analysis on metatrader.com as part of your research.